How can dynamic disease modeling support strategic marketing at pharmaceutical & biotech companies?

Summary form only given. Dynamic disease models integrate disparate information sources, such as epidemiology, treatment dynamics and market behavior, to create a virtual test bed that can be used to identify leverage points and market prospects for to-be-launched products. These models are effective in exploring a wide scenario space that influence key strategic marketing decisions. We present a methodology for disease modeling that has been applied to seven distinct acute and chronic conditions in the past year.